Previous studies reported a promotion of anti-tumor immunity of CD8+ T cells with an increased production of proinflammatory cytokines like IFN-γ, granzyme B and perforin and enhanced efficacy of chemotherapy through the production of metabolites, such as butyrate (10). This evidence concerns the gene PRF1 and neoplasm.